This document summarizes an enterprise called Rx&You that aims to revolutionize healthcare delivery through personalized medication recommendations. It analyzes large amounts of patient data using AI to determine which medications work best for which patients, with the goal of improving outcomes, safety, and reducing healthcare costs by billions per year. The company was founded in 2015 and believes its approach can help address problems like medication non-adherence that impact millions worldwide.

1. Enterprise & Predictive Intelligence for Medications
Rx&YouTM
The Prospect of Delivering Billions in Value
ERIC LUELLEN | STEVE HELMS | JEFFREY WEISS | ED CUMMINGS

2. Purpose & Meaning
2015
11 Multi
Billion $
Prospects
Interested
We are on a mission to revolutionize healthcare delivery by learning which medications work
best for which patients, maximizing clinical outcomes and medication safety while dramatically
reducing the cost of healthcare, thereby saving millions of lives and billions of dollars per year.
Based in Boston Team of 6Started in 2015 Social Proof

3. Medication
non-adherence
Adverse drug
events
Many
disconnected
doctors
Which drugs for
whom & when?
Problems of Global Scale
1 billion cases per year
75 million US patients
don’t take their
medications properly;
rest-of-world is worse.
Inefficient Market =
Millions of lives and billions of dollars lost every year
1.5 million US AE/year
8% of patients have
serious & costly
events; 300K seniors &
180K are fatal.
Disorganized teams
US adults see 18-28
docs in life with little
coordination of what
each are doing.=
Pharmacogenomics -
Personalized medicine
416 million drug
combos for 7 billion
people; few know
which works for whom

4. Market Size
$535 billion
per year
$214 billion
per year
$21 billion
per year
Total Available Market
Preventable medical
expenses from medication
non-adherence (MNA) &
adverse events (AE).
Serviceable Available Market
Maximum improvement
possible in preventing medical
expenses from MNA & AE.
Serviceable Obtainable Market
Minimum improvement possible
in preventing medical expenses
from MNA & AE.

5. Providers receive team-
wide reports and real-
time alerts from
platform’s AI rules and
predictive analytics.
Providers prioritize risks
& intervene, preventing
expensive medical
consequences by getting
the right info at right
times.
Our cloud platform
ingests and collects
streams of patient data,
and transforms it into
meaning and acts.
Solution
Patients receive alerts &
education how they
prefer, when & how to
take their medications,
tracking behavior and
side effects.

6. Our Product
30 National Health Services
Est. $100 billion/year of
preventable medical
expenses from med non-
adherence and adverse
events.
20 Major Heath Insurers
Est. $114 billion/year of
preventable medical expenses
from med non-adherence and
adverse events.
1 billion cases per year
75 million US patients
don’t take their
medications properly;
rest-of-world is worse.
Creates sustainable growth
By winning the race to
biggest-best data fastest, we
can win the race to infonomics
and personalized medicine.
We are inventing the future of medication healthcare.
By combining five technologies of the future we can learn and rank the
effectiveness of every medication for every patient while maximizing
care quality and dramatically reducing its cost simultaneously.

7. Testimonials
“An immense need and
consequent opportunity.”
“It’s interesting; it has the
marks of a good idea. I think
you’re onto something.”
“A very promising solution
to one of the Holy Grails of
modern medicine.”
“AI and CEP to develop a drug-
event system that screens for
drug interactions in real time
and alerts, etc. is innovative. “
Robert Herjavec,
CEO, The Herjavec Group,
Star of “Shark Tank”
Dr. Eric Isselbacher, Director,
Healthcare Transformation Lab,
Mass. Gen. Hospital
Dr. David Luckham, Professor,
Stanford University
(Emeritus)
Chris Coburn,
Chief Innovation Officer,
Partners Healthcare

8. Pilot Endorsements ProspectsAwards
Social Proof Traction
Press

9. Why Now?
“I think the biggest
innovations of the 21st
century will be the
intersection of biology and
technology; a new era is
beginning.”
Steve Jobs

10. Business Model
B2B2C Patients
Payers, providers,
or pharmas add
patients in large
cohorts from one
sale or license.
Patient Savings
An est. $5,000 per
patient per year in
prevented medical
expenses.
75M $5,000
Subscription Model
75M x $5K /year x 10%
= a $37.5B sustainable
company BEFORE going
international.
$37.5Bx =
We take a 10% fee of savings of preventable medical expenses.
Value-based Pricing
We keep 10% of
money saved from
preventable medical
events.
10%x

11. Medication
Adherence
Pharmaco
-genomics
(PM)
BPaaS
IoT AI
Pharmaco
-kinetics
(PK)
Competitive Landscape
Rx&YouTM

12. Competitive Advantages
First to Market
For AI & IoT across all
medication delivery in
real-time – an 18-24
month market lead
Best-of-Breed
28 best intervention
approaches – dozens more
than competitors – layered
to maximize care and value
Personalized Medicine
Ability to add patients’
genomic variants means
owning the knowledge to
match meds to patients
Coordinates Care
Docs & pharma, for the first
time, can see across systems
to know and coordinate
patient treatment.

13. Killer Team
Steve Helms, Co-founder & CTO
• Led development for 18 months
• Serial technology entrepreneur
• 20 years software development experience
• BBA from Texas A&M
Jeffrey Weiss, Chief Operating Officer
• 20 years global management experience
• Former White House advance leader
• Advised dozens of sovereign states &
Fortune 500 companies
Ed Cummings, Chief Marketing Officer
• Product manager @ Microsoft for 12 years
• Led $30B IP acquisition @ Microsoft
• JD from University of Minnesota
Advisors
Amy Odom, Advisor
• Health insurance executive for 19 years
• Partner @ Denton’s – World’s largest
polycentric law firm – in healthcare
• Represents national payers
Samantha Surrey, Advisor
• Works with MD Anderson on the Moonshot
• Former M&A executive – GSK
• 16 years in pharma and med device innovation
• Sold 3D protein-folding venture to Microsoft
• MSE from University of Penn, BS from Cornell
Eric Luellen, Co-founder & CEO
• Former CTO medical software company
• 20 years experience leading IT solutions to
Fortune 500 companies as entrepreneur
• MS in health informatics @ Northwestern

14. Milestones
The Idea
September 2015
Founders have new
idea to improve
medication
adherence.
First Demo
February 2016
The first demo of
RX&You™ given at
Massachusetts
General Hospital.
Provisional Patent
April 2016
RX&You™ patents
filed at US Patent
Office advised by
Fenwick & West.
C3 Prize Finalist
September 2016
RX&You™ chosen
as a top 5 finalist &
audience favorite
at Stanford MedX.
Found by Press
September 2016
Eligible says
RX&You™ 1 of 7
healthcare start-ups
you should know.
World Tech Finalist
November 2016
RX&You™ chosen
as 1 of 6 global
finalists for WTN
Award in health
and medicine.